Two global haemostatic assays as additional tools to monitor treatment in cases of haemophilia A

¹Coagulation Research, Institute for Molecular Medicine and Surgery, Karolinska Institutet, and Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden; ²Hemostasis Department and Hemophilia Centre, Blood Transfusion Institute of Serbia, Belgrade, Serbia; ³Clinic of Hematology, Clinical Centre of Serbia & Faculty of Medicine, University of Belgrade, Belgrade, Serbia; ⁴Coagulation Unit, Hematology Centre, Karolinska University Hospital, Stockholm, Sweden; and ⁵Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden